Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells

Sherer, Christopher and Tolaymat, Ibrahim and Rowther, Farzana and Warr, Tracy and Snape, Timothy J. (2017) Preliminary SAR on indole-3-carbinol and related fragments reveals a novel anticancer lead compound against resistant glioblastoma cells. Bioorganic & Medicinal Chemistry Letters. ISSN 0960-894X (Accepted)

[img] Text
Accepted Version
Restricted to Repository staff only until 17 February 2018.
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (730kB)
[img] Other (Acceptance)
Other
Restricted to Repository staff only
Available under the following license: Creative Commons Attribution Non-commercial No Derivatives.

Download (126kB)
Official URL: https://doi.org/10.1016/j.bmcl.2017.02.033

Abstract

The prognosis for glioblastoma patients is, at best, poor, with the median time of survival after diagnosis measured in months. As such, there is much need for the rapid development of potent and novel treatments. Herein, we report our preliminary findings on the SAR of a series of indole-3-carbinol and related fragments and reveal a potent lead with low micromolar activity against a particularly resistant glioblastoma cell culture, providing a new platform for future development of a new therapy in this area.

Item Type: Journal Article
Keywords: cancer, indole-3-carbinol, glioblastoma
Faculty: Faculty of Medical Science
Depositing User: Ibrahim Tolaymat
Date Deposited: 01 Mar 2017 16:37
Last Modified: 01 Mar 2017 16:37
URI: http://arro.anglia.ac.uk/id/eprint/701528

Actions (login required)

Edit Item Edit Item